Project Abstract

Abstract
MicroRNAs (miRNAs) have emerged as key regulators of gene expression and play critical roles in various biological processes, including cancer development and progression. This research project aims to explore the intricate role of miRNAs in cancer, focusing on their involvement in tumor initiation, growth, metastasis, and drug resistance. The study will investigate how dysregulation of miRNAs can promote oncogenesis by targeting specific genes and pathways, leading to aberrant cell proliferation, invasion, and evasion of immune surveillance. The research will begin with a comprehensive literature review to provide a detailed understanding of the current knowledge on miRNAs and their implications in cancer biology. This review will highlight key miRNAs that have been identified as oncogenic or tumor-suppressive in various cancer types, as well as their mechanisms of action and clinical relevance. The methodology section will outline the experimental approaches to be employed in this study, including the use of cell culture models, bioinformatics analysis, and functional assays to validate the role of specific miRNAs in cancer progression. The research will also involve the analysis of patient samples to correlate miRNA expression profiles with clinical outcomes and treatment responses. The findings from this study will be discussed in detail in the results section, focusing on the identification of specific miRNAs that are dysregulated in different stages of cancer development and their impact on tumor behavior. The research will also investigate the potential of miRNAs as diagnostic biomarkers and therapeutic targets for cancer treatment, highlighting their promise in personalized medicine approaches. In conclusion, this research project will shed light on the complex interplay between miRNAs and cancer, providing valuable insights into the molecular mechanisms underlying tumor progression. The findings of this study have the potential to advance our understanding of cancer biology and contribute to the development of novel diagnostic and therapeutic strategies for improved patient outcomes in oncology.

Project Overview